Advertisement
Advertisement
MDWD
MediWound Ltd.
15.74
USDSponsored
-1.24
-7.31%
Mar 26, 15:59 UTC -4
Closed
After-Market
15.74
0.00
+0.01%
MDWD Earnings Reports
Positive Surprise Ratio
MDWD beat 22 of 40 last estimates.
55%
Next Report
Date of Next Report
May 19, 2026
Estimate for Q1 26 (Revenue/ EPS)
$3.67M
/-$0.66
Implied change from Q4 25 (Revenue/ EPS)
+96.52%
/+17.86%
Implied change from Q1 25 (Revenue/ EPS)
-7.23%
/+842.86%
MediWound Ltd. earnings per share and revenue
On Mar 05, 2026, MDWD reported earnings of -0.56 USD per share (EPS) for Q4 25, beating the estimate of -0.64 USD, resulting in a 13.08% surprise. Revenue reached 1.87 million, compared to an expected 6.23 million, with a -70.05% difference. The market reacted with a -0.85% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 6 analysts forecast an EPS of -0.66 USD, with revenue projected to reach 3.67 million USD, implying an increase of 17.86% EPS, and increase of 96.52% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Context Therapeutics Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.14
Surprise
-29.39%
Avalo Therapeutics, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$1.49
Actual
-$1.12
Surprise
+24.33%
Journey Medical Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.04
Surprise
+31.86%
Surrozen, Inc. Common
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$1.21
Actual
-Surprise
-
Achieve Life Sciences, Inc.
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.12%
Vivani Medical, Inc. Common Stock (DE)
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.09
Surprise
-
Pyxis Oncology, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Acrivon Therapeutics, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.47
Actual
-$0.52
Surprise
-9.34%
Fractyl Health, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
$0.15
Surprise
+181.70%
NRX Pharmaceuticals, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.01
Surprise
-361.54%
FAQ
What were MediWound Ltd.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, MediWound Ltd. reported EPS of -$0.56, beating estimates by 13.08%, and revenue of $1.87M, -70.05% below expectations.
How did the market react to MediWound Ltd.'s Q4 2025 earnings?
The stock price moved down -0.85%, changed from $17.60 before the earnings release to $17.45 the day after.
When is MediWound Ltd. expected to report next?
The next earning report is scheduled for May 19, 2026.
What are the forecasts for MediWound Ltd.'s next earnings report?
Based on 6
analysts, MediWound Ltd. is expected to report EPS of -$0.66 and revenue of $3.67M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement